CD7 and cancer: Reported markers for MICs included CD44+/CD7+/Met+/CD45−, and dual epithelial and mesenchymal markers.14,15 As stated before MICs comprise only an extremely small fraction of CTCs and theoretically will be more difficult to be detected in the peripheral venous blood of patients with nonmetastatic cancer.